Coloplast As Sp/Adr (CLPBY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 09/30
(Values in U.S. thousands)
| 12-2025 | 09-2025 | 06-2025 | 03-2025 | 12-2024 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 175,388 | 140,251 | 110,425 | 102,862 | 129,467 |
| Receivables | 761,260 | 766,566 | 872,446 | 784,657 | 769,231 |
| Inventories | 601,618 | 580,404 | 574,482 | 535,757 | 524,872 |
| TOTAL | $1,605,458 | $1,548,089 | $1,605,568 | $1,476,894 | $1,481,301 |
| Non-Current Assets | |||||
| PPE Net | 1,009,608 | 918,368 | 904,387 | 839,404 | 832,250 |
| Investments And Advances | 14,031 | 13,329 | 14,450 | 13,405 | 13,576 |
| Intangibles | 4,704,438 | 4,461,809 | 4,550,224 | 4,404,013 | 4,378,456 |
| Other Non-Current Assets | 273,761 | 221,557 | 207,920 | 201,633 | 201,918 |
| TOTAL | $6,001,838 | $5,615,063 | $5,676,980 | $5,458,454 | $5,426,199 |
| Total Assets | $7,607,296 | $7,163,153 | $7,282,548 | $6,935,347 | $6,907,500 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 587,275 | 548,859 | 335,685 | 477,341 | 598,751 |
| Other current liabilities | 548,456 | 353,663 | 1,024,850 | 949,039 | 1,036,311 |
| TOTAL | $1,235,975 | $963,391 | $1,605,111 | $1,547,444 | $1,824,119 |
| Non-Current Liabilities | |||||
| Long Term Debt | 3,231,807 | 2,866,179 | 2,519,384 | 2,337,322 | 2,366,710 |
| Other Non-Current Liabilities | 987,471 | 945,915 | 656,312 | 660,065 | 507,295 |
| TOTAL | $4,219,278 | $3,812,094 | $3,175,696 | $2,997,387 | $2,874,005 |
| Total Liabilities | $5,455,253 | $4,775,484 | $4,780,807 | $4,544,831 | $4,698,124 |
| Shareholders' Equity | |||||
| Common Shares | 35,545 | 33,767 | 34,679 | 32,171 | 32,581 |
| Retained earnings | 2,343,489 | 2,016,826 | 2,557,257 | 2,297,813 | 2,360,422 |
| Other shareholders' equity | -226,990 | 337,075 | -90,195 | 60,532 | -183,626 |
| TOTAL | $2,152,044 | $2,387,668 | $2,501,741 | $2,390,516 | $2,209,377 |
| Total Liabilities And Equity | $7,607,297 | $7,163,152 | $7,282,548 | $6,935,347 | $6,907,501 |